𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation of the BRCA1 antibody MS110 and the utility of BRCA1 as a patient selection biomarker in immunohistochemical analysis of breast and ovarian tumours

✍ Scribed by Roy Milner, Helen Wombwell, Sonia Eckersley, Donna Barnes…

Book ID
120906581
Publisher
Springer
Year
2013
Tongue
English
Weight
706 KB
Volume
462
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Analysis of BRCA1 and BRCA2 in breast an
Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula
✍ A. VEGA; M. TORRES; J. I. MARTÍNEZ; C. RUIZ-PONTE; F. BARROS; A. CARRACEDO 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

An estimated 5–10% of all breast and ovarian cancers are due to an inherited predisposition, representing a rather large number of patients. In Spain 1/13–1/14 women will be diagnosed with breast cancer during their lifetime. Two major breast cancer genes, __BRCA1__ and __BRCA2__, have been identifi

Mutation analysis of the BRCA1 and BRCA2
Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease
✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi